Trident Lifeline Stock Screener | Share Price & Fundamental Analysis
TLL
Pharmaceuticals
Track Trident Lifeline share price live with TickJournal's free stock screener.
Analyze Trident Lifeline share price history trends and compare 52-week high low
levels.
Calculate TLL stock fair value using fundamental analysis and view live share price charts.
Determine Trident Lifeline share intrinsic value and compare it with current TLL share price.
Record your Trident Lifeline trades in TickJournal's free trading journal and track your portfolio performance.
Trident Lifeline Market Cap
₹320.75 Cr.
TLL P/E Ratio (TTM)
15.00
EPS (TTM)
₹10.22
Dividend Yield
-
Debt to Equity
0.62
Trident Lifeline 52 Week Low
-
Operating Margin
23.00%
Profit Margin
16.13%
TLL Revenue (TTM)
₹31.00
EBITDA
₹9.00
Net Income
₹5.00
Total Assets
₹156.00
Total Equity
₹70.00
Trident Lifeline Share Price History - Stock Screener Chart
Screen TLL historical share price movements with interactive charts. Analyze price trends and patterns.
Trident Lifeline Company Profile - Fundamental Screener
Screen Trident Lifeline company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for TLL shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE0MKA01014
Trident Lifeline Balance Sheet Screener
Screen TLL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Assets | ||||
| Total Assets | 156 | 87 | 63 | 14 |
| Current Assets | 90 | 52 | 49 | 11 |
| Fixed Assets | 44 | 21 | 3 | 1 |
| Liabilities | ||||
| Total Liabilities | 156 | 87 | 63 | 14 |
| Current Liabilities | 33 | 13 | 4 | 2 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||
| Total Equity | 70 | 54 | 47 | 5 |
| Share Capital | 12 | 12 | 12 | 8 |
| Reserves & Surplus | 53 | 40 | 34 | -3 |
Trident Lifeline Income Statement Screener - Profit & Revenue Analysis
Screen Trident Lifeline income statement and profit fundamentals.
Analyze TLL quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Trident Lifeline share price evaluation.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept | 2022-Jun | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 31 | 25 | 36 | 12 | 16 | 14 | 21 | 7 | 10 | 9 | 9 | 10 | 8 | 6 | 9 |
| Expenses | 23 | 18 | 26 | 8 | 11 | 11 | 17 | 6 | 8 | 7 | 7 | 7 | 6 | 5 | 7 |
| EBITDA | 9 | 7 | 10 | 5 | 5 | 4 | 4 | 2 | 3 | 2 | 3 | 2 | 2 | 1 | 2 |
| Operating Profit % | 23.00% | 22.00% | 25.00% | 34.00% | 26.00% | 19.00% | 12.00% | 20.00% | 22.00% | 20.00% | 23.00% | 21.00% | 18.00% | 14.00% | 20.00% |
| Depreciation | 1 | 2 | 3 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 1 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 7 | 4 | 6 | 4 | 4 | 3 | 3 | 1 | 2 | 2 | 2 | 2 | 2 | 1 | 2 |
| Tax | 2 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | -1 |
| Net Profit | 5 | 3 | 6 | 3 | 3 | 2 | 2 | 1 | 2 | 1 | 2 | 2 | 1 | 1 | 3 |
| EPS | 4.27 | 2.66 | 6.15 | 2.42 | 2.69 | 1.99 | 1.41 | 0.94 | 1.48 | 1.22 | 1.72 | 1.77 | 1.15 | 0.88 | 15.02 |
Trident Lifeline Cash Flow Screener - Liquidity Fundamentals
Screen TLL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|
| Operating Activities | -10 | 2 | -19 | 0 |
| Investing Activities | -14 | -20 | -10 | 0 |
| Financing Activities | 20 | 11 | 42 | 1 |
| Net Cash Flow | -4 | -7 | 14 | 0 |
Trident Lifeline Shareholding Pattern Screener
See Trident Lifeline shareholding pattern with promoter, FII, and DII holdings.
Check Trident Lifeline promoter holding and ownership changes for TLL on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 63.04% | 63.04% | 63.11% | 63.26% | 67.48% | 65.51% | 62.99% | 62.99% |
| FII Holding | 6.62% | 7.21% | 7.71% | 7.56% | 6.02% | 6.02% | 6.09% | 6.09% |
| DII Holding | 0.09% | 0.39% | 0.41% | 0.38% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 18.26% | 17.90% | 17.63% | 17.34% | 16.39% | 18.37% | 19.40% | 18.90% |
| Other Holding | 11.99% | 11.45% | 11.14% | 11.46% | 10.10% | 10.10% | 11.52% | 12.02% |
| Shareholder Count | 534 | 549 | 554 | 549 | 500 | 502 | 507 | 523 |
Trident Lifeline Share Dividend Screener - Share Yield Analysis
Check Trident Lifeline dividend history with payout and yield data.
View Trident Lifeline dividend details including ex-dates and amounts for TLL stock.
Trident Lifeline Stock Index Membership
See which indices include Trident Lifeline stock.
Check TLL index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Trident Lifeline Market Events Screener - Corporate Actions
Get Trident Lifeline corporate actions including splits, bonuses, and buybacks.
Check Trident Lifeline stock events that may affect TLL share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -0.35% | ||
| Annual General Meeting | NA | 18.05% | ||
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | 1.43% |
| 2025-07-28 | 2025-07-28 | Quarterly Result Announcement | NA | 1.19% |
| 2025-05-09 | 2025-05-09 | Extraordinary General Meeting | NA | 13.60% |
| 2025-04-28 | 2025-04-28 | Quarterly Result Announcement | NA | 5.19% |
| 2025-01-22 | 2025-01-22 | Quarterly Result Announcement | NA | 5.83% |
| 2024-10-19 | 2024-10-19 | Quarterly Result Announcement | NA | 4.93% |
Trident Lifeline Competitors Screener - Peer Comparison
Screen TLL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 416,764 | 40.16 | 54,729 | 9.71% | 10,980 | 41.99 |
| Divis Laboratories | 172,462 | 69.16 | 9,712 | 18.67% | 2,191 | 54.95 |
| Torrent Pharmaceuticals | 129,770 | 60.40 | 11,539 | 6.99% | 1,911 | 64.03 |
| Cipla | 120,864 | 22.30 | 28,410 | 7.12% | 5,291 | 43.36 |
| Dr Reddys Laboratories | 105,645 | 18.66 | 33,741 | 16.73% | 5,725 | 50.22 |
| Lupin | 96,238 | 22.21 | 22,910 | 13.74% | 3,306 | 58.72 |
| Zydus Life Science | 92,352 | 18.57 | 23,511 | 18.55% | 4,615 | 41.66 |
| Mankind Pharma | 90,530 | 51.90 | 12,744 | 20.90% | 2,007 | 47.28 |
| Aurobindo Pharma | 70,358 | 20.66 | 32,346 | 9.43% | 3,484 | 55.09 |
| Alkem Laboratories | 66,550 | 27.75 | 13,458 | 3.70% | 2,216 | 44.89 |
Trident Lifeline Company Announcements - News Screener
Screen TLL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-03-06 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2026-03-06 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2026-03-03 | Board Meeting Outcome for Outcome Of Board Meeting Held On Today I.E. On December 16 2025 In Terms Of Second Proviso To Regulation 30(6) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2026-03-03 | Announcement under Regulation 30 (LODR)-Allotment | View |
| 2025-12-10 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-12-05 | Announcement under Regulation 30 (LODR)-Allotment | View |
| 2025-12-05 | Board Meeting Outcome for Outcome Of Board Meeting Held On Today I.E. On December 05 2025 In Terms Of Second Proviso To Regulation 30(6) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-11-21 | Announcement under Regulation 30 (LODR)-Allotment | View |
| 2025-11-21 | Announcement under Regulation 30 (LODR)-Resignation of Director | View |
| 2025-11-21 | Board Meeting Outcome for Outcome Of Board Meeting Held On Today I.E. On November 21 2025 In Terms Of Second Proviso To Regulation 30(6) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015- Allotment Of Securities | View |
| 2025-11-14 | Revised Unaudited Financial Results For The Half Year Ended September 30 2025. | View |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-11 | Result-Financial Result For The Half Year Ended 30.09.2025 | View |
| 2025-11-11 | Board Meeting Outcome for Outcome Of Board Meeting Held On 11.11.2025 | View |
| 2025-11-04 | Board Meeting Intimation for Declaration Of Un-Audited Result For Half Year Ended 30.09.2025 | View |
| 2025-10-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-29 | Closure of Trading Window | View |
| 2025-09-29 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-27 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |